AND ANSWERS
A person with a substance use disorder. - -Which of the following is an example of person first, medically
appropriate terminology?
-alcohol - -Which of the following is the most common substance use disorder in the United States?
-all of the above - -Efficacy studies show that buprenorphine
-all of the above - -Federal regulation allows buprenorphine to be prescribed in a clinic or office by the
following prescribers:
-all of the above - -Which of the following conditions is associated with substance use disorders?
-all of the above - -Which of the following is useful for chronic, collaborative substance use disorder
management in primary care?
-ask open ended questions, affirm the patient's experiences, etc. - -Which of the following strategies
should be used to engage patients in discussions on problematic substance use to improve the likelihood
of a successful brief intervention or referral to treatment?
-borderline personality disorder - -Which of the following patients would require a higher level of care
(i.e. inpatient admission) for concurrent treatment of substance use and psychiatric comorbidity?
-cause and controllability - -What factors influence stigma?
-clean - -Please select the term which should not be used from the list below:
-drug use disorder - -Which of the following was found by the World Health Organization to be the
number 1 most stigmatized condition?
-evaluation of medication safety and efficacy - -Medication management for the treatment of opioid use
disorder includes the following:
-extended release naltrexone - -This medication for the treatment of opioid use disorder does not
currently have evidence showing that it reduces transmission of HIV and HCV:
-heritability, influenced by environmental conditions and behavior, and the ability to respond to
appropriate treatment - -Substance use disorder shares many features with other chronic illnesses
including:
-methadone - -Full opioid agonists produce increasing mu opioid receptor specific activity until
maximum opioid agonist effects are achieved and no further effects can be produced, even by giving
more medication. An example of a full opioid agonist is: